Retrobulbar optic neuritis after pamidronate administration in a patient with a history of cutaneous porphyria

被引:13
作者
DesGrottes, JM [1 ]
Schrooyen, M [1 ]
Dumon, JC [1 ]
Body, JJ [1 ]
机构
[1] INST JULES BORDET,BONE METAB UNIT,MED SERV,B-1000 BRUSSELS,BELGIUM
关键词
pamidronate; bisphosphonates; optic neuritis; porphyria; osteoporosis;
D O I
10.1007/BF02238770
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe the case of a patient who developed reversible retrobulbar optic neuritis after intravenous pamidronate therapy for established osteoporosis. This possible complication has never been previously reported and, since our patient had a history of porphyria, it suggests that bisphosphonates should be administered cautiously in patients with this disease.
引用
收藏
页码:93 / 95
页数:3
相关论文
共 15 条
[1]  
BODY J-J, 1992, Current Opinion in Oncology, V4, P624, DOI 10.1097/00001622-199208000-00005
[2]   TREATMENT OF TUMOR-INDUCED HYPERCALCEMIA WITH THE BISPHOSPHONATE PAMIDRONATE - DOSE-RESPONSE RELATIONSHIP AND INFLUENCE OF TUMOR TYPE [J].
BODY, JJ ;
DUMON, JC .
ANNALS OF ONCOLOGY, 1994, 5 (04) :359-363
[3]  
DESNICK RJ, 1991, HEMATOLOGY BASIC PRI, P352
[4]   PAMIDRONATE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN RESORPTIVE BONE-DISEASE [J].
FITTON, A ;
MCTAVISH, D .
DRUGS, 1991, 41 (02) :289-318
[5]  
FLEISCH H, 1993, OSTEOPOROSIS INT, V2, pS15
[6]   PAMIDRONATE DISODIUM AND POSSIBLE OCULAR ADVERSE DRUG-REACTIONS [J].
MACAROL, V ;
FRAUNFELDER, FT .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1994, 118 (02) :220-224
[7]   CONGENITAL ERYTHROPOIETIC PORPHYRIA - SKELETAL MANIFESTATIONS AND EFFECT OF PAMIDRONATE TREATMENT [J].
OLIVERI, MB ;
MAUTALEN, C ;
MEGA, M ;
ROSSI, E .
BONE, 1994, 15 (01) :101-104
[8]  
SAUTY A, 1994, BONE MINER S1, V25, pS69
[9]  
SCHWEITZER DH, 1995, J BONE MINER RES, V10, P956
[10]   OCULAR INVOLVEMENT IN CUTANEOUS PORPHYRIA - CLINICAL AND HISTOLOGICAL REPORT [J].
SEVEL, D ;
BURGER, D .
ARCHIVES OF OPHTHALMOLOGY, 1971, 85 (05) :580-+